Dapagliflozin and urine metabolome in patients with type 2 diabetes.

Like Comment
Inhibitors of sodium-glucose cotransporters-2 have cardio- and renoprotective properties. However, the underlying mechanisms remain indeterminate.To evaluate the effect of dapagliflozin on renal metabolism assessed by urine metabolome analysis in patients with type 2 diabetes.Prospective cohort study.Outpatient diabetes clinic of a tertiary academic centre.Eighty patients with HbA1c> 7% on metformin monotherapy were prospectively enrolled.Fifty patients were treated with dapagliflozin for 3 months. To exclude that the changes observed in urine metabolome were merely the result of the improvement in glycemia, 30 patients treated with insulin degludec were used for comparison.Main Outcome Measure: Changes in urine metabolic profile before and after the administration of dapagliflozin and insulin degludec were assessed by Proton-Nuclear Magnetic Resonance spectroscopy (1H-NMR).In multivariate analysis urine metabolome was significantly altered by dapagliflozin (R 2X=0.819, R 2Y=0.627, Q 2Y=0.362, and CV-ANOVA, p<0.001) but not insulin. After dapagliflozin the urine concentrations of ketone bodies, lactate, branched chain amino acids (p<0.001), betaine, myo-inositol (p<0001) and N-Methylhydantoin (p< 0.005) were significantly increased. Additionally, the urine levels of alanine, creatine, sarcosine and citrate were also increased (p<0001, <0.0001 and <0.0005, respectively) whereas anserine decreased (p<0005).Dapagliflozin significantly affects urine metabolome in patients with type 2 diabetes in a glucose lowering-independent way. Most of the observed changes can be considered beneficial and may contribute to the renoprotective properties of dapagliflozin.

View the full article @ The Journal of clinical endocrinology and metabolism

Get PDF with LibKey
Authors: Evdoxia Bletsa, Sebastien Filippas-Dekouan, Christina Kostara, Panagiotis Dafopoulos, Aikaterini Dimou, Eleni Pappa, Styliani Chasapi, Georgios Spyroulias, Anastasios Koutsovasilis, Eleni Bairaktari, Ele Ferrannini, Vasilis Tsimihodimos


The wider, wiser view for healthcare professionals. ClinOwl signposts the latest clinical content from over 100 leading medical journals.
6577 Contributions
0 Following